Literature DB >> 27343791

Oxytocin in cesarean-sections. What's new?

Eduardo Tsuyoshi Yamaguchi1, Mônica Maria Siaulys2, Marcelo Luis Abramides Torres3.   

Abstract

Oxytocin is the uterotonic agent of choice in the prevention and treatment of postpartum uterine atony. Nevertheless, there is no consensus on the optimal dose and rate for use in cesarean sections. The use of high bolus doses (e.g., 10IU of oxytocin) can determine deleterious cardiovascular changes for the patient, especially in situations of hypovolemia or low cardiac reserve. Furthermore, high doses of oxytocin for prolonged periods may lead to desensitization of oxytocin receptors in myometrium, resulting in clinical inefficiency.
Copyright © 2015 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Cesarean section; Cesariana; Desensitization; Dessensibilização; Dose; Ocitocina; Oxytocin

Mesh:

Substances:

Year:  2016        PMID: 27343791     DOI: 10.1016/j.bjane.2014.11.015

Source DB:  PubMed          Journal:  Braz J Anesthesiol


  2 in total

1.  Route of oxytocin administration for preventing blood loss at caesarean section: a systematic review with meta-analysis.

Authors:  Maria Regina Torloni; Monica Siaulys; Rachel Riera; Ana Luiza Cabrera Martimbianco; Rafael Leite Pacheco; Carolina de Oliveira Cruz Latorraca; Mariana Widmer; Ana Pilar Betran
Journal:  BMJ Open       Date:  2021-09-16       Impact factor: 2.692

2.  Carbetocin Controls Intraoperative Blood Loss and Thickness of Myometrium in Scar Uterus Cases.

Authors:  Dongjing Sun
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-04       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.